25CN-NBOMe, also known as 2C-CN-NBOMe or NBOMe-2C-CN, is a derivative of the phenethylamine 2C-CN. It acts in a similar manner to related compounds such as 25I-NBOMe, which are potent agonists at the serotonin 5-HT<sub>2A</sub> receptor.
25CN-NBOMe acts as a potent and selective agonist of the serotonin 5-HT<sub>2A</sub> receptor. To a lesser extent, it also acts as an agonist of the serotonin 5-HT<sub>2B</sub> and 5-HT<sub>2C</sub> receptors.
25CN-NBOMe was first described in the scientific literature by 2010.
25CN-NBOMe is a controlled substance in Canada under phenethylamine blanket-ban language.